Association between serum 25(OH)D and death from prostate cancer.
about
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic reviewVitamin D pathway gene variants and prostate cancer prognosisVitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological EvidenceVitamin D and Immune Response: Implications for Prostate Cancer in African AmericansCirculating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Development and validation of a liquid chromatography-tandem mass spectrometry assay for serum 25-hydroxyvitamin D2/D3 using a turbulent flow online extraction technology.Cohort Profile: The Janus Serum Bank Cohort in Norway.The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysisOpen letter to IARC Director Christopher P. Wild-Re: IARC Working Group Report 5: Vitamin D and CancerPrediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial.Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.Vitamin D supplements and cancer incidence and mortality: a meta-analysis.Vitamin D and cancer: a review of molecular mechanismsDietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation.Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.VITamin D supplementation in renAL transplant recipients (VITALE): a prospective, multicentre, double-blind, randomized trial of vitamin D estimating the benefit and safety of vitamin D3 treatment at a dose of 100,000 UI compared with a dose of 12,0Seasonal variations of cancer incidence and prognosis.The association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer.Vitamin d, sunlight and prostate cancer riskPreliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexiaSerum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study.Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medicationsThe relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer.Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 MenPrediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance.Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature.Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.Vitamin d: are we ready to supplement for breast cancer prevention and treatment?Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.The sum of many small changes: microRNAs are specifically and potentially globally altered by vitamin D3 metabolites.Vitamin D in cutaneous carcinogenesis: part IBiomarkers in prostate cancer epidemiology.Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma.Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial.Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.Vitamin D deficiency/insufficiency from childhood to adulthood: Insights from a sunny country.
P2860
Q22305894-7680A279-5074-465A-98AF-61586E293856Q24628345-DC871F60-7360-46C2-9FB6-63D4DD17163BQ26766256-F8E5A1AB-AB93-4BA0-8CE8-67F3B44A7832Q26768536-AD826298-D996-4867-AF46-A786C3B62446Q27336054-31A545B8-6280-40CE-8642-1B13E431E0BFQ33444010-34086430-F190-4A55-94E5-341D25892130Q33458121-8B36A2F9-1817-416F-9978-3F4F8413468FQ33577607-6200D2FF-17EC-480F-B517-818B5686EAADQ33716965-38EB975E-F240-4A90-8828-8141370C6D0EQ33873649-CCD91613-519E-41A4-B387-6F14B5A8699DQ33992150-3627BE0F-CAB5-4AAC-8EFF-63AB190172CFQ34026909-2249D076-0EFD-4F88-9B12-B4FC729ACA3CQ34113467-B1AD42DA-6099-4515-9C0E-7262AE6FD71EQ34240570-4F2C4810-02F3-4A09-8230-4761047CE37CQ34345056-6192594E-7048-4EA1-BDAB-9C35114CDEDBQ34383359-70AA1DDE-3BD2-468B-8732-6B7B1BC4C37BQ34397763-538A651F-8EC2-44C9-AE7D-A257E7C88A07Q34517376-0D02D5E7-8145-403E-A40C-0EF77E95289AQ34847240-453A2EB4-EB0A-4B40-85CC-AC5DB6F9204AQ35182320-0FC903F5-A8D8-44E1-941E-956EFD7A6A67Q35207472-2C5F6666-7E78-4C23-B283-1942B2352455Q35599827-F53B0127-85D5-4AAA-A762-4169F04A1987Q35681151-017FF2AB-B433-4E9E-9478-F6446A061580Q35740351-465361A7-257F-4C35-9170-D78F73B9A0E6Q35878551-491381BA-0DE0-4CA8-B31F-8F27C1E4393FQ35961214-1792762B-47C3-4BC9-947A-FDB0071EA0F2Q36043460-8BF82CA3-1E49-4D3E-B6E7-704304CA2666Q36069763-EC6F348C-DF8D-4C96-A80F-8AC04F6C645EQ36230495-8353016E-C676-428F-8CF7-9EB4B14EEA6EQ36468811-7B6E4906-406F-41F2-A482-3354D80B7400Q36514160-116E5229-4D24-4A2A-9650-17FBC4444143Q36692336-9120AC07-0451-4857-A9EA-9F806EC9D574Q36917872-72709FB9-F209-4A1C-8083-A48EFC1662DDQ36941178-4D4EDCF2-4B39-4E94-A789-E355974307E0Q36944593-05597DDA-F941-40FA-B805-63753F362EAAQ37148139-28D26FA7-0019-4BE6-A356-A91B1CA23230Q37351839-19E3DFF8-6EFF-4A45-ADEE-2BDEFFC42CF5Q37590639-D256C360-1E46-475B-AED7-87D01BBEB43AQ37611428-3F4D9DCA-AA4E-4AA7-B073-EF87832DC310Q37630289-55BEAC07-BCD9-44C0-8A46-48C60119C2BD
P2860
Association between serum 25(OH)D and death from prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between serum 25(OH)D and death from prostate cancer.
@en
type
label
Association between serum 25(OH)D and death from prostate cancer.
@en
prefLabel
Association between serum 25(OH)D and death from prostate cancer.
@en
P2093
P2860
P356
P1476
Association between serum 25(OH)D and death from prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604865
P407
P577
2009-01-20T00:00:00Z
P5875
P6179
1024302940